{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:32:19Z","timestamp":1740137539332,"version":"3.37.3"},"reference-count":57,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T00:00:00Z","timestamp":1524614400000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Hemodialysis International"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatitis C virus (HCV) is a common cause of increased morbidity and mortality in kidney transplant patients. It is associated with posttransplant glomerulonephritis, chronic allograft nephropathy, and New Onset Diabetes after Transplant (NODAT). In the past, HCV was difficult to treat due to the presence of interferon alpha\u2010based therapies that were difficult to tolerate and were associated with adverse side\u2010effects, such as the risk of rejection. With the advent of oral directly acting antiviral therapies, the landscape for HCV and transplantation has changed. These agents are highly effective and well tolerated with minimal side\u2010effects. Sustained viral response rates in excess of 90% are achieved with most current treatment regimens active against all HCV genotypes. These new agents may show an improvement in graft and patient survival while essentially eliminating the risk of acute rejection from the use of prior interferon\u2010based HCV therapies. These agents may also result in an improvement in organ allocation for HCV donor\/HCV recipient transplantation. This review is meant to discuss the epidemiology of HCV, the new oral direct\u2010acting antiviral agents (DAAs) and future opportunities for research in the field of HCV related transplantation.<\/jats:p>","DOI":"10.1111\/hdi.12659","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T13:50:47Z","timestamp":1524664247000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hepatitis C virus infection in kidney transplantation\u2010changing paradigms with novel agents"],"prefix":"10.1111","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1974-5216","authenticated-orcid":false,"given":"Yuvaram N. V.","family":"Reddy","sequence":"first","affiliation":[{"name":"Department of Medicine Boston University Medical Center Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Nunes","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology Boston University Medical Center Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vipul","family":"Chitalia","sequence":"additional","affiliation":[{"name":"Renal Section Boston University Medical Center Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig E.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Renal Section Boston University Medical Center Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean M.","family":"Francis","sequence":"additional","affiliation":[{"name":"Renal Section Boston University Medical Center Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,4,25]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/593291"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.12410"},{"volume-title":"Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report","year":"2016","author":"National Academies of Sciences, Engineering, and Medicine","key":"e_1_2_9_4_1"},{"key":"e_1_2_9_5_1","unstructured":"Global Observatory on Donation and Transplantation.http:\/\/www.transplant-observatory.org\/"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.28576"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.01.012"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00649.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/039139880903200801"},{"key":"e_1_2_9_10_1","first-page":"35","article-title":"Novel antiviral agents for the treatment of HCV among renal transplant recipients]","volume":"34","author":"Fabrizi F","year":"2017","journal-title":"G Ital Nefrol."},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.5414\/CNP58143"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1086\/315355"},{"key":"e_1_2_9_13_1","first-page":"S31","article-title":"Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients","volume":"7","author":"Taneja S","year":"2017","journal-title":"Nephrology (Carlton)."},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2016.02.050"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181f92548"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.09.018"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12847"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02930806"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i1.55"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/039139880803100801"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001197"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13055"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12148"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182848de2"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000089090"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090611"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.06.003"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1159\/000355615"},{"key":"e_1_2_9_29_1","unstructured":"AASLD\u2010IDSA. Recommendations for testing managing and treating hepatitis C. Available from:www.hcvguidelines.rg. September 21 2017."},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(17)30444-0"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13518"},{"key":"e_1_2_9_32_1","first-page":"e890","article-title":"Early results of pilot study using hepatitis C virus (HCV) positive kidneys to transplant HCV infected patients with end\u2010stage renal disease allowing for successful interferon\u2010free direct acting antiviral therapy after transplantation","volume":"8","author":"Gallegos\u2010Orozco JF","year":"2016","journal-title":"Cureus."},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-1205"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.12.020"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158431"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-017-0745-5"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001414"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001618"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12954"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12941"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13620"},{"key":"e_1_2_9_42_1","first-page":"1105","article-title":"THINKER Trial Investigators. Transplanting HCV\u2010infected kidneys into uninfected recipients","volume":"377","author":"Goldberg DS","year":"2017","journal-title":"N Engl J Med."},{"key":"e_1_2_9_43_1","unstructured":"AASLD\u2010IDSA HCV Guidance: Recommendations for Testing Managing and Treating Hepatitis C.http:\/\/www.hcvguidelines.org\/unique-populations\/renal-impairment. September 17 2017."},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i32.5969"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02510317"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402454"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00349-9"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512610"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.20411\/pai.v2i3.211"},{"key":"e_1_2_9_50_1","unstructured":"AASLD\u2010IDSA HCV Guidance: Recommendations for Testing Managing and Treating Hepatitis C.https:\/\/www.hcvguidelines.org\/unique-populations\/kidney-transplant. September 17 2017."},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3852126"},{"key":"e_1_2_9_52_1","first-page":"2065","article-title":"Sofosbuvir\u2010based antiviral therapy in hepatitis C virus patients with severe renal failure","volume":"32","author":"Dumortier J","year":"2017","journal-title":"Nephrol Dial Transplant."},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001410"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03091.x"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017060673"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000145439.48387.BF"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000012382.97168.E0"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0553-2"}],"container-title":["Hemodialysis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhdi.12659","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hdi.12659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T03:27:28Z","timestamp":1694489248000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hdi.12659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":57,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1111\/hdi.12659"],"URL":"https:\/\/doi.org\/10.1111\/hdi.12659","archive":["Portico"],"relation":{},"ISSN":["1492-7535","1542-4758"],"issn-type":[{"type":"print","value":"1492-7535"},{"type":"electronic","value":"1542-4758"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"2018-01-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}